Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?

Yıl: 2017 Cilt: 28 Sayı: 1 Sayfa Aralığı: 16 - 21 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?

Öz:
Ambulatory esophageal pH monitoring is an essential method in patients exhibiting signs of non-erosive reflux disease (NERD) to make an objective diagnosis. Intra-esophageal pH monitoring is important in patients who are non-responsive to medications and in those with extraesophageal symptoms, particularly in NERD, before surgical interventions. With the help of the wireless capsule pH monitoring, measurements can be made under more physiological conditions as well as longer recordings can be performed because the investigation can be better tolerated by patients. Ambulatory esophageal pH monitoring can be detected within normal limits in 17%-31.4% of the patients with endoscopic esophagitis; therefore, normal pH monitoring cannot exclude the diagnosis of gastroesophageal reflux disease (GERD). Multi-channel intraluminal impedance pH (MII-pH) technology have been developed and currently the most sensitive tool to evaluate patients with both typical and atypical reflux symptoms. The sensitivity of a pH catheter test is 58% for the detection of acid reflux compared with MII-pH monitoring; further, its sensitivity is 28% for the detection of weak acid reflux compared with MII-pH monitoring. By adding impedance to pH catheter in patients with reflux symptoms, particularly in those receiving PPIs, it has been demonstrated that higher rates of diagnoses and symptom analyses can be obtained than those using only pH catheter. Esophageal manometry is used in the evaluation of patients with functional dysphagia and unexplained noncardiac chest pain and prior to antireflux surgery. The use of esophageal manometry is suitable for the detection of esophageal motor patterns and extreme motor abnormalities (e.g., achalasia and extreme hypomotility). Esophageal manometry and ambulatory pH monitoring are often used in assessments prior to laparoscopic antireflux surgery and in patients with reflux symptoms refractory to medical treatment. Although the esophageal motility is predominantly normal in patients with non-acid reflux, ineffective esophageal motility is often monitored in patients with acid reflux. In the literature, there are contradictory and an insufficient number of studies regarding radiological methods for the diagnosis of GERD. There are inconsistent values for sensitivity and specificity among the barium studies. There are inadequate studies in the literature involving scintigraphic examinations in the diagnosis of GERD, and a majority of existing studies have been conducted in the pediatric group. The results of a few studies do not provide sufficient contribution toward the implementation in clinical practice
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO. The symptom index: a clinically important parameter of ambulatory 24- hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 358-61.
  • 2. Cabrera J, Davis M, Horn D, Pfefferkorn M, Croffie JM. Esophageal pH monitoring with the BRAVO capsule: experience in a single tertiary medical center. J Pediatr Gastroenterol Nutr 2011; 53: 404-8.
  • 3. Croffie JM, Fitzgerald JF, Molleston JP, et al. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years. J Pediatr Gastroenterol Nutr 2007; 45: 559-63. [CrossRef]
  • 4. Wenner J, Johnsson F, Johansson J, Oberg S. Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scand J Gastroenterol 2005; 40: 768-74. [CrossRef]
  • 5. Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98: 740-9. [CrossRef]
  • 6. Ward EM, Devault KR, Bouras EP, et al. Successful oesophageal pH monitoring with a catheter-free system. Aliment Pharmacol Ther 2004; 19: 449-54. [CrossRef]
  • 7. Ayazi S, Lipham JC, Portale G, et al. Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. Clin Gastroenterol Hepatol 2009; 7: 60-7. [CrossRef]
  • 8. Pandolfino JE. Bravo capsule pH monitoring. Am J Gastroenterol 2005; 100: 8-10. [CrossRef]
  • 9. des Varannes SB, Mion F, Ducrotte P, et al. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut 2005; 54: 1682-6. [CrossRef]
  • 10. Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110: 1982-96. [CrossRef]
  • 11. Pandolfino JE, Zhang Q, Schreiner MA, Ghosh S, Roth MP, Kahrilas PJ. Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different? Gut 2005; 54: 1687-92.
  • 12. Bhat YM, McGrath KM, Bielefeldt K. Wireless esophageal pH monitoring: new technique means new questions. J Clin Gastroenterol 2006; 40: 116-21. [CrossRef]
  • 13. Gillies RS, Stratford JM, Booth MI, Dehn TC. Oesophageal pH monitoring using the Bravo catheter-free radio capsule. Eur J Gastroenterol Hepatol 2007; 19: 57-63. [CrossRef]
  • 14. Remes-Troche JM, Ibarra-Palomino J, Carmona-Sanchez RI, Valdovinos MA. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico. Am J Gastroenterol 2005; 100: 2382-6. [CrossRef]
  • 15. Fass R, Hell R, Sampliner RE, et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 1999; 44: 2263-9. [CrossRef]
  • 16. Mearin F, Balboa A, Dot J, Maldonado O, Malagelada JR. How standard is a standard day during a standard ambulatory 24-hour esophageal pH monitoring? Scand J Gastroenterol 1998; 33: 583-5.
  • 17. DeVault KR, Castell DO. Current diagnosis and treatment of gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 867-76. [CrossRef]
  • 18. Klauser AG, Heinrich C, Schindlbeck NE, Muller-Lissner SA. Is longterm esophageal pH monitoring of clinical value? Am J Gastroenterol 1989; 84: 362-6.
  • 19. Masclee AA, de Best AC, de Graaf R, Cluysenaer OJ, Jansen JB. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy. Scand J Gastroenterol 1990; 25: 225-30.
  • 20. Nasi A, Filho JP, Zilberstein B, Cecconello I, Gama-Rodrigues JJ, Pinotti HW. Gastroesophageal reflux disease: clinical, endoscopic, and intraluminal esophageal pH monitoring evaluation. Dis Esophagus 2001; 14: 41-9. [CrossRef]
  • 21. Schlesinger PK, Donahue PE, Schmid B, Layden TJ. Limitations of 24-hour intraesophageal pH monitoring in the hospital setting. Gastroenterology 1985; 89: 797-804. [CrossRef]
  • 22. Johnson LF, Demeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974; 62: 325-32.
  • 23. Azzam RS, Sallum RA, Brandao JF, Navarro-Rodriguez T, Nasi A. Comparative study of two modes of gastroesophageal reflux measuring: conventional esophageal pH monitoring and wireless pH monitoring. Arq Gastroenterol 2012; 49: 107-12. [CrossRef]
  • 24. Hakanson BS, Berggren P, Granqvist S, Ljungqvist O, Thorell A. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring. Scand J Gastroenterol 2009; 44: 276-83. [CrossRef]
  • 25. Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 1741-5. [CrossRef]
  • 26. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102-11.
  • 27. Johnsson F, Joelsson B, Isberg PE. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut 1987; 28: 1145-50. [CrossRef]
  • 28. Mattioli S, Pilotti V, Spangaro M, et al. Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 1989; 34: 71-8. [CrossRef]
  • 29. Schindlbeck NE, Heinrich C, Konig A, Dendorfer A, Pace F, MullerLissner SA. Optimal thresholds, sensitivity, and specificity of longterm pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 1987; 93: 85-90. [CrossRef]
  • 30. Vitale GC, Sadek S, Tulley FM, et al. Computerized 24-hour esophageal pH monitoring: a new ambulatory technique using radiotelemetry. J Lab Clin Med 1985; 105: 686-93.
  • 31. Sweis R, Fox M, Anggiansah A, Wong T. Prolonged, wireless pHstudies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies. Neurogastroenterol Motil 2011; 23: 419-26. [CrossRef]
  • 32. Ang D, Teo EK, Ang TL, et al. To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort. J Dig Dis 2010; 11: 19-27. [CrossRef]
  • 33. Nasi A, Frare Rde C, Brandao JF, Falcao AM, Muchelsohn NH, Sifrim D. Comparative prospective study of two positioning modes of 24-hour esophageal pH monitoring: by esophageal manometry and by the pH step-up technique. Arq Gastroenterol 2008; 45: 261-7. [CrossRef]
  • 34. Hirano I. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring. Aliment Pharmacol Ther 2006; 23(Suppl 1): 12-24.
  • 35. Tutuian R. Update in the diagnosis of gastroesophageal reflux disease. J Gastrointestin Liver Dis 2006; 15: 243-7.
  • 36. Castell DO, Mainie I, Tutuian R. Non-acid gastroesophageal reflux: documenting its relationship to symptoms using multichannel intraluminal impedance (MII). Trans Am Clin Climatol Assoc 2005; 116: 321-34.
  • 37. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-31. [CrossRef]
  • 38. Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004; 99: 1037-43. [CrossRef]
  • 39. Sifrim D. Acid, weakly acidic and non-acid gastro-oesophageal reflux: differences, prevalence and clinical relevance. Eur J Gastroenterol Hepatol 2004; 16: 823-30. [CrossRef]
  • 40. Sifrim D, Holloway R, Silny J, et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pHimpedance recordings. Gastroenterology 2001; 120: 1588-98. [CrossRef]
  • 41. Pandolfino JE, Vela MF. Esophageal-reflux monitoring. Gastrointest Endosc 2009; 69: 917-31. [CrossRef]
  • 42. Zentilin P, Dulbecco P, Savarino E, Giannini E, Savarino V. Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. Dig Liver Dis 2004; 36: 565-9. [CrossRef]
  • 43. Bredenoord AJ, Weusten BL, Curvers WL, Timmer R, Smout AJ. Determinants of perception of heartburn and regurgitation. Gut 2006; 55: 313-8. [CrossRef]
  • 44. Savarino E, Bazzica M, Zentilin P, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 2009; 179: 408-13. [CrossRef]
  • 45. Tutuian R, Mainie I, Agrawal A, Adams D, Castell DO. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006; 130: 386-91. [CrossRef]
  • 46. Sifrim D, Dupont L, Blondeau K, Zhang X, Tack J, Janssens J. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 2005; 54: 449-54. [CrossRef]
  • 47. Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol 2008; 103: 2685-93. [CrossRef]
  • 48. Bredenoord AJ, Weusten BL, Timmer R, Conchillo JM, Smout AJ. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006; 101: 453-9. [CrossRef]
  • 49. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006; 101: 1956-63. [CrossRef]
  • 50. Pohl D, Tutuian R. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements. Best Pract Res Clin Gastroenterol 2009; 23: 299-311. [CrossRef]
  • 51. Masiak W, Wallner G, Wallner J, Pedowski T, Solecki M. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications. Pol Przegl Chir 2011; 83: 488-96. [CrossRef]
  • 52. Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedancepH off therapy. Am J Gastroenterol 2010; 105: 1053-61. [CrossRef]
  • 53. Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Characteristics of gastroesophageal reflux in symptomatic patients with and without excessive esophageal acid exposure. Am J Gastroenterol 2006; 101: 2470-5. [CrossRef]
  • 54. Emerenziani S, Sifrim D, Habib FI, et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut 2008; 57: 443-7. [CrossRef]
  • 55. Tutuian R, Vela MF, Hill EG, Mainie I, Agrawal A, Castell DO. Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol 2008; 103: 1090-6. [CrossRef]
  • 56. Frazzoni M, Savarino E, Manno M, et al. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther 2009; 30: 508-15. [CrossRef]
  • 57. Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis 2011; 43: 542-7. [CrossRef]
  • 58. Hila A, Agrawal A, Castell DO. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol 2007; 5: 172-7. [CrossRef]
  • 59. Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol 2009; 7: 743-8. [CrossRef]
  • 60. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedancepH monitoring. Gut 2006; 55: 1398-402. [CrossRef]
  • 61. Dent J. A new technique for continuous sphincter pressure measurement. Gastroenterology 1976; 71: 263-7.
  • 62. Clouse RE, Staiano A, Alrakawi A, Haroian L. Application of topographical methods to clinical esophageal manometry. Am J Gastroenterol 2000; 95: 2720-30. [CrossRef]
  • 63. Clouse RE, Staiano A. Topography of normal and high-amplitude esophageal peristalsis. Am J Physiol 1993; 265: G1098-107.
  • 64. Clouse RE, Staiano A, Alrakawi A. Development of a topographic analysis system for manometric studies in the gastrointestinal tract. Gastrointest Endosc 1998; 48: 395-401. [CrossRef]
  • 65. Staiano A, Clouse RE. Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors. Am J Gastroenterol 2001; 96: 3258-67. [CrossRef]
  • 66. Aymerich R, Prakash C, Clouse RE. Topographic esophageal manometric methods help clarify the diagnosis of aperistaltic disorders. Gastroenterology 2002; 122: A340-A1.
  • 67. Sarani B, Gleiber M, Evans SR. Esophageal pH monitoring, indications, and methods. J Clin Gastroenterol 2002; 34: 200-6. [CrossRef]
  • 68. Younes Z, Johnson DA. Diagnostic evaluation in gastroesophageal reflux disease. Gastroenterol Clin North Am 1999; 28: 809-30. [CrossRef]
  • 69. Chan WW, Haroian LR, Gyawali CP. Value of preoperative esophageal function studies before laparoscopic antireflux surgery. Surg Endosc 2011; 25: 2943-9. [CrossRef]
  • 70. Wang VS, Feldman N, Maurer R, Burakoff R. Esophageal motility in nonacid reflux compared with acid reflux. Dig Dis Sci 2009; 54: 1926-32. [CrossRef]
  • 71. Neumann CH, Forster CF. Gastroesophageal reflux--reassessment of the value of fluoroscopy based on manometric evaluation of the lower esophageal segment. Am J Gastroenterol 1983; 78: 776-9.
  • 72. Thompson JK, Koehler RE, Richter JE. Detection of gastroesophageal reflux: value of barium studies compared with 24-hr pH monitoring. AJR Am J Roentgenol 1994; 162: 621-6. [CrossRef]
  • 73. Fiorentino E, Barbiera F, Cabibi D, et al. Barium study associated with water siphon test in gastroesophageal reflux disease and its complications. Radiol Med 2007; 112: 777-86. [CrossRef]
  • 74. Aksglaede K, Funch-Jensen P, Thommesen P. Radiological demonstration of gastroesophageal reflux. Diagnostic value of barium and bread studies compared with 24-hour pH monitoring. Acta Radiol 1999; 40: 652-5. [CrossRef]
  • 75. Fisher RS, Malmud LS, Roberts GS, Lobis IF. Gastroesophageal (GE) scintiscanning to detect and quantitate GE reflux. Gastroenterology 1976; 70: 301-8.
  • 76. De Gregorio BT, Fennerty MB, Wilson RA. Noninvasive diagnosis of gastroesophageal inflammation using dipyridamole thallium-201 tomography. Am J Gastroenterol 1998; 93: 1255-9. [CrossRef]
  • 77. Hsu CH, Shiun SC, Hsu NY, et al. Using non-invasive radionuclide imaging to detect esophagitis in patients with gastroesophageal reflux disease. Hepato-Gastroenterol 2003; 50: 107-9.
APA VARDAR R, Keskin M (2017). Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. , 16 - 21.
Chicago VARDAR Rukiye,Keskin Muharrem Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. (2017): 16 - 21.
MLA VARDAR Rukiye,Keskin Muharrem Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. , 2017, ss.16 - 21.
AMA VARDAR R,Keskin M Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. . 2017; 16 - 21.
Vancouver VARDAR R,Keskin M Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. . 2017; 16 - 21.
IEEE VARDAR R,Keskin M "Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?." , ss.16 - 21, 2017.
ISNAD VARDAR, Rukiye - Keskin, Muharrem. "Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?". (2017), 16-21.
APA VARDAR R, Keskin M (2017). Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. Turkish Journal of Gastroenterology, 28(1), 16 - 21.
Chicago VARDAR Rukiye,Keskin Muharrem Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. Turkish Journal of Gastroenterology 28, no.1 (2017): 16 - 21.
MLA VARDAR Rukiye,Keskin Muharrem Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. Turkish Journal of Gastroenterology, vol.28, no.1, 2017, ss.16 - 21.
AMA VARDAR R,Keskin M Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. Turkish Journal of Gastroenterology. 2017; 28(1): 16 - 21.
Vancouver VARDAR R,Keskin M Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?. Turkish Journal of Gastroenterology. 2017; 28(1): 16 - 21.
IEEE VARDAR R,Keskin M "Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?." Turkish Journal of Gastroenterology, 28, ss.16 - 21, 2017.
ISNAD VARDAR, Rukiye - Keskin, Muharrem. "Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?". Turkish Journal of Gastroenterology 28/1 (2017), 16-21.